Synthesis of some pyrazolo[1,5-c][1,3]benzoxazines and a new 5H-pyrazolo[1,5-c][1,3,2]benzoxazaphosphorine ring system

Journal of Heterocyclic Chemistry

Volumn 42, Issue 6, 2005, Pages 1143-1147

  Svetlik, Jan ^a   Pronayova, Nada ^b   Kubista, Jiri ^c  

^a Physics and Informatics   (Slovakia)

^b SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^c J HEYROVSKÝ INSTITUTE OF PHYSICAL CHEMISTRY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

1,1'B DIHYDRO 5 (4 METHOXYPHENYL) 2 METHYL 5H PYRAZOLO[1,5 C][1,3,2]BENZOXAZAPHOSPHORIN 5 SULFIDE; 5 (2 HYDROXYPHENYL)PYRAZOLINE; 5H PYRAZOLO[1,5 C][1,3,2]BENZOXAZOPHOSPHORINE; BENZOXAZINE DERIVATIVE; CARBONYLDIIMIDAZOLE; GLYOXYLIC ACID; HETEROCYCLIC COMPOUND; LAWESSON REAGENT; PYRAZOLE DERIVATIVE; PYRAZOLINE DERIVATIVE; PYRAZOLO[1,5 C][1,3]BENZOXAZINE DERIVATIVE; REAGENT; TEREPHTHALALDEHYDIC ACID; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

EID: 24944448674     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570420616     Document Type: Article

References (23)

1. J. Svetlik and L. Sallai, J. Heterocyclic Chem., 39, 363 (2002).
2. J. Svetlik and T. Liptaj, J. Chem. Soc., Perkin Trans I, 1260 (2002).
3. I. I. Grandberg, V. P. Din and A. N. Kost, Zh. Obshch. Khim., 30, 1373 (1960);
4. Chem. Abstr., 55, 517i (1961).
5. A. Levai, J. Heterocyclic Chem., 39, 1 (2002).
6. V. D. Orlov, N. V. Getmanskii, I. A. Oksanich and S. V. Iksanova, Khim. Geterotsikl. Soedin., 1131 (1991);
7. Chem. Abstr., 116, 194239s (1992).
8. S. M. Desenko, N. V. Getmanskii, V. N. Chernenko, I. M. Zemlin, O. V. Shishkin and V. D. Orlov, Khim. Geterotsikl. Soedin., 805 (1999);
9. Chem. Abstr., 132, 180531z (2000).
10. G. A. M. Nawwar, J. Chem. Research (S), 344 (1991).
11. F. Varano, D. Catarzi, V. Colotta, L. Cecchi, G. Filacchioni, A. Galli and C. Costagli. Arch. Pharm., 329, 529 (1996).
12. G. A. Higgs, R. J. Flower and J. R. Vane, Biochem. Pharmacol., 28, 1959 (1979).
13. F. C. Copp, P. J. Islip and J. E. Tateson, Biochem. Pharmacol., 33, 339 (1984).
14. Y. Jahng, L. X. Zhao, Y. S. Moon, A. Basnet, E. Kim, H. W. Chang, H. K. Ju, T. C. Jeong and E. S. Lee, Bioorg. Med. Chem. Lett., 14, 2559 (2004).
15. R. R. Ramatunge, M. Augustyniuk, U. P. Bandarage, R. A. Earl, J. L. Ellis, D. S. Garvey, D. R. Janero, L. G. Letts, A. M. Martino, M. G. Murty, S. K. Richardson, J. D. Schroeder, M. J. Shumway, S. W. Tam, A. M. Trocha and D. V. Young, J. Med. Chem., 47, 2180 (2004).
16. K. Subbaramaiah, L. Norton, W. Gerald and A. J. Dannenberg, J. Biol Chem., 277, 18649 (2002).
17. G. M. Pasinetti, Arch. Gerontol. Geriatr., 33, 13 (2001).
18. D. E. Leyden and R. H. Cox, Analytical Applications of NMR. John Wiley & Sons, New York 1977, p. 185.
19. M. Jesberger, T. P. Davis and L. Barner, Synthesis, 1929 (2003).
20. B. S. Pedersen and S. O. Lawesson, Tetrahedron, 35, 2433 (1979).
21. A. A. El-Barbary and S. O. Lawesson, Tetrahedron, 37, 2641 (1981).
22. K. Kostka and M. Porada, Arch. Pharm., 325, 325 (1992).
23. K. Kostka, M. Porada, E. Zyner, W. Pakulska and A. Sadlowska, Arch. Pharm., 330, 203 (1997).